Prehab the Labs: Predicting Surgical Outcomes in Spine Fractures Through Preoperative Lab Values

术前实验室检查:通过术前实验室检查值预测脊柱骨折手术结果

阅读:1

Abstract

Study DesignRetrospective Cohort Study.ObjectivesTo evaluate the prognostic utility of preoperative laboratory values (PLVs) in predicting 30-day postoperative outcomes among patients undergoing single-level vertebral fracture fixation.MethodsThe ACS-NSQIP database (2015-2020) was queried to identify adults who underwent single-level vertebral fracture fusion. Patients were stratified by PLV categories using clinically relevant hypo- and hyper-thresholds. Outcomes included 30-day mortality, major complications, Clavien-Dindo IV complications, non-home discharge (NHD), readmission, reoperation, and extended length of stay. Multivariate logistic regression adjusted for demographics and comorbidities was used to assess associations between PLVs and adverse outcomes.ResultsA total of 4005 patients were identified. Hypoalbuminemia emerged as the strongest independent predictor of poor outcomes, including mortality (OR 4.05, 95% CI 2.14-7.69, P < 0.001), major complications (OR 1.94, 95% CI 1.46-2.57, P < 0.01), and NHD (OR 1.72, 95% CI 1.37-2.17, P < 0.001). Elevated creatinine and leukocytosis were significantly associated with increased mortality (P = 0.047) and Clavien-Dindo IV complications (P < 0.001), while preoperative anemia predicted prolonged hospitalization (P < 0.01).ConclusionsAmong patients undergoing single-level vertebral fixation for fracture, hypoalbuminemia is the most consistent predictor of adverse 30-day outcomes. Elevated creatinine, leukocytosis, and anemia also confer independent risks for specific complications. Incorporating PLVs into preoperative risk stratification may enhance patient counseling, optimize perioperative planning, and identify candidates for targeted prehabilitation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。